Answer
Anzupgo (delgocitinib) cream has low potential to interact with systemic medicines because of limited metabolism, application to a limited area (hands and wrists) and minimal systemic exposure, although no clinical interaction studies have been performed.
Sources for this answer
- Anzupgo 20 mg/g creamLeo Laboratories Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 2Document updated
Sources checked